P. Hulse

510 citations

18 papers · 358 indexed · h-index 9

Impact in

Oncology
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
Pulmonary and Respiratory Medicine
- Lung Cancer Treatments and Mutations
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis

Papers in ⓘ

Oncology 8
- Vascular Tumors and Angiosarcomas 2
- Lung Cancer Research Studies 2
- Cancer Immunotherapy and Biomarkers 2
Otorhinolaryngology 1

Co-authors: Paul Lorigan (4 shared papers)Bernadette M. Carrington (8 shared papers)Peter Trainer (1 shared paper)Claire Higham (1 shared paper)Fiona Blackhall (2 shared papers)Malcolm Ranson (1 shared paper)Sarah Danson (1 shared paper)Corinne Faivre‐Finn (2 shared papers)
Journals: Clinical Radiology (4 papers)Lung Cancer (2 papers)Journal of Clinical Oncology (2 papers)British Journal of Cancer (1 paper)The Journal of Laryngology & Otology (1 paper)
Partner nations: United Kingdom Belarus

In The Last Decade

P. Hulse

18 papers receiving 348 citations

Peers

Countries citing papers authored by P. Hulse

Since Specialization

Citations

This map shows the geographic impact of P. Hulse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Hulse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Hulse more than expected).

Fields of papers citing papers by P. Hulse

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Hulse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Hulse. The network helps show where P. Hulse may publish in the future.

Co-authors

The 25 scholars most cited alongside P. Hulse, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with P. Hulse Line = papers co-authored together P. Hulse links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work
1	Hyponatraemia secondary to nivolumab-induced primary adrenal failure Endocrinology Diabetes and Metabolism Case Reports ·Harris Trainer, P. Hulse, Claire Higham, Peter Trainer, Paul Lorigan	2016	88
2	Magnetic resonance imaging of anal cancer Clinical Radiology ·Steve Roach, P. Hulse, Fenella Moulding, R. Wilson, Bernadette M. Carrington	2005	51
3	Interstitial Lung Disease in Lung Cancer Drug Safety ·Sarah Danson, Fiona Blackhall, P. Hulse, Malcolm Ranson	2005	49
4	Adult growth hormone replacement therapy and neuroimaging surveillance in brain tumour survivors Clinical Endocrinology ·Andreas Jostel, Annice Mukherjee, P. Hulse, Stephen M. Shalet	2005	38
5	The role of positron emission tomography in management of small cell lung cancer Lung Cancer ·David Thomson, P. Hulse, Paul Lorigan, Corinne Faivre‐Finn	2011	30
6	Omitting elective nodal irradiation during thoracic irradiation in limited-stage small cell lung cancer – Evidence from a phase II trial Lung Cancer ·Rovel Colaco, Hamid Sheikh, Paul Lorigan, Fiona Blackhall, P. Hulse, Raffaele Califano, Linda Ashcroft, Paul Taylor, Nicholas Thatcher, Corinne Faivre‐Finn	2011	25
7	Magnetic Resonance Appearance of Normal Inguinal Nodes Clinical Radiology ·A.C. GREY, Bernadette M. Carrington, P. Hulse, R Swindell, William B Yates	2000	24
8	Should FDG-PET scanning be routinely used for patients with an unknown head and neck squamous primary? The Journal of Laryngology & Otology ·P Silva, P. Hulse, Andrew Sykes, Bernadette M. Carrington, P. J. Julyan, Jarrod J. Homer, D. L. Hastings, N.J. Slevin	2006	13
9	Imatinib with cisplatin in recurrent and/or metastatic salivary adenoidcystic carcinoma – response assessed by FDG-PET scanning Journal of Clinical Oncology ·N.J. Slevin, K. Mais, Iain Bruce, Timothy H. Ward, Bernadette M. Carrington, P. Hulse, Susana Banerjee, P. J. Julyan, Andrew Sykes, Jarrod J. Homer	2004	10
10	Do radiographic features of acute infection influence management of lower respiratory tract infections in the community? European Respiratory Journal ·J. Simpson, P. Hulse, PM Taylor, M. Woodhead	1998	6
11	MRI Manual of Pelvic Cancer P. Hulse, Bernadette M. Carrington	2004	6
12	Corynebacterium jeikeium meningitis and transverse myelitis in a neutropenic patient European Journal of Clinical Microbiology & Infectious Diseases ·A. Johnson, P. Hulse, B. Oppenheim	1992	6
13	Multiple primary malignancies associated with a germline SMARCB1 pathogenic variant Familial Cancer ·Judith Eelloo, Miriam J. Smith, Naomi L. Bowers, John Ealing, P. Hulse, James Wylie, Patrick Shenjere, Noel W. Clarke, Calvin Soh, Richard W. Whitehousé, Mark Jones, Christopher Duff, Anthony J. Freemont, D. Gareth Evans	2019	5
14	Abdominopelvic CT scan findings after surgery for ovarian cancer Clinical Radiology ·Rameez Razzaq, Bernadette M. Carrington, P. Hulse, Henry C Kitchener	1998	2
15	Imatinib with cisplatin in recurrent and/or metastatic salivary adenoidcystic carcinoma – response assessed by FDG-PET scanning Journal of Clinical Oncology ·N.J. Slevin, K. Mais, Iain Bruce, Timothy H. Ward, Bernadette M. Carrington, P. Hulse, Sube Banerjee, P. J. Julyan, Andrew Sykes, Jarrod J. Homer	2004	2
16	Continuous infusion of 5-fluorouracil with alpha 2b interferon for advanced colorectal carcinoma British Journal of Cancer ·JE Ferguson, P. Hulse, Paul Lorigan, Gordon C. Jayson, J H Scarffe	1995	1
17	Localized perforation into the transverse mesocolon demonstrated during barium enema — rare but benign Clinical Radiology ·P. Hulse, R. W. J. Hartley, D.F. Martin	1994	1
18	P20. The use of FDG and 124I PET in the localization and characterization of recurrent thyroid carcinoma Nuclear Medicine Communications ·P. J. Julyan, Jordan Fenton, D. L. Hastings, J. Bailey, Jamal Zweit, Bernadette M. Carrington, P. Hulse, Jeremy Lawrance, E. Allan	2002	1

About P. Hulse

P. Hulse is a scholar working on Oncology, Otorhinolaryngology, Periodontics, Endocrinology and Gastroenterology, having authored 18 papers that have together received 358 indexed citations. Recurring topics across this work include Colorectal and Anal Carcinomas (4 papers), Vascular Tumors and Angiosarcomas (2 papers), Salivary Gland Tumors Diagnosis and Treatment (2 papers), Lung Cancer Research Studies (2 papers), Sarcoma Diagnosis and Treatment (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Lung Cancer Treatments and Mutations (2 papers) and Neuroendocrine Tumor Research Advances (2 papers). The work is most often cited by research in Oncology (201 citations), Pulmonary and Respiratory Medicine (135 citations), Otorhinolaryngology (17 citations), Neurology (53 citations) and Epidemiology (118 citations). P. Hulse has collaborated with scholars based in United Kingdom and Belarus. Frequent co-authors include Paul Lorigan, Bernadette M. Carrington, Peter Trainer, Claire Higham, Fiona Blackhall, Malcolm Ranson, Sarah Danson, Corinne Faivre‐Finn, Stephen M. Shalet and R. Wilson. Their work appears in journals such as Clinical Radiology, Lung Cancer, Journal of Clinical Oncology, British Journal of Cancer and The Journal of Laryngology & Otology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact